Vimpat 150 mg/1 (Lacosamide TABLET, FILM COATED) 150 mg/1

Vimpat 150 mg is an oral medication containing lacosamide, used to manage certain types of seizures. This film-coated tablet is designed for convenient administration and is manufactured by UCB, Inc. in the USA.

Strength

150 mg/1

Pack Size

6 BLISTER PACK in 1 CARTON (0131-2479-60) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

UCB, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vimpat 150 mg is primarily used as an adjunctive therapy for the treatment of partial-onset seizures in adults with epilepsy. Lacosamide, the active ingredient, works by stabilizing electrical activity in the brain. This medication is often prescribed when other treatments have not been fully effective. It is important to follow the advice of a healthcare provider regarding the use of Vimpat 150 mg for seizure management.

Side Effects

Common effects of Vimpat 150 mg may include dizziness, headache, and nausea. Some individuals might experience fatigue or double vision. These effects can vary from person to person and may subside as the body adjusts to the medication. It is advisable to consult a healthcare professional if any effects are persistent or severe.

Precautions & Warnings

Vimpat 150 mg should be handled with care, especially by individuals with a history of heart conditions or psychiatric disorders. It is important to inform a healthcare provider about any other medications being taken to avoid potential interactions. Pregnant or breastfeeding women should discuss the use of Vimpat 150 mg with their healthcare provider before starting treatment.

Avoid Interactions

Vimpat 150 mg may interact with other medications, including those that affect the central nervous system. Alcohol consumption should be avoided as it can enhance the sedative effects of lacosamide. It is crucial to consult a healthcare provider before combining Vimpat 150 mg with any other treatments to ensure safety and effectiveness.

Frequently Asked Questions

Vimpat 150 mg is used as an adjunctive therapy for managing partial-onset seizures in adults with epilepsy.

Vimpat 150 mg should be taken orally, following the instructions provided by a healthcare provider.

Common side effects may include dizziness, headache, and nausea. Some individuals might also experience fatigue or double vision.

It is important to consult a healthcare provider before combining Vimpat 150 mg with other medications to avoid potential interactions.

Pregnant women should discuss the use of Vimpat 150 mg with their healthcare provider before starting treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.